BCL2 and Obesity: Thus, ER positivity, Bcl-2 positivity and p53 negativity, which co-occurred in a majority of breast cancer cases in the present analyses, all appear to be part of a more general molecular constellation that could be driven by obesity, even though more experimental insight is needed to better understand the interplay between obesity and these tumor characteristics.